Human Mesenchymal Precursor Cells (Stro-1) from Spinal Cord Injury Patients Improve Functional Recovery and Tissue Sparing in an Acute Spinal Cord Injury Rat Model

This study aimed to determine the potential of purified (Stro-1 + ) human mesenchymal precursor cells (hMPCs) to repair the injured spinal cord (SC) after transplantation into T-cell-deficient athymic RNU nude rats following acute moderate contusive spinal cord injury (SCI). hMPCs were isolated from...

Full description

Bibliographic Details
Main Authors: Stuart I. Hodgetts, Paul J. Simmons, Giles W. Plant
Format: Article
Language:English
Published: SAGE Publishing 2013-03-01
Series:Cell Transplantation
Online Access:https://doi.org/10.3727/096368912X656081
_version_ 1818846990758313984
author Stuart I. Hodgetts
Paul J. Simmons
Giles W. Plant
author_facet Stuart I. Hodgetts
Paul J. Simmons
Giles W. Plant
author_sort Stuart I. Hodgetts
collection DOAJ
description This study aimed to determine the potential of purified (Stro-1 + ) human mesenchymal precursor cells (hMPCs) to repair the injured spinal cord (SC) after transplantation into T-cell-deficient athymic RNU nude rats following acute moderate contusive spinal cord injury (SCI). hMPCs were isolated from the bone marrow (BM) stroma of SCI patients and transplanted as a suspension graft in medium [with or without immunosuppression using cyclosporin A (CsA)]. Extensive anatomical analysis shows statistically significant improvement in functional recovery, tissue sparing, and cyst reduction. We provide quantitative assessment of supraspinal projections in combination with functional outcomes. hMPC-transplanted animals consistently achieved mean BBB scores of 15 at 8 weeks postinjury. Quantitative histological staining revealed that graft-recipient animals possessed more intact spinal tissue and reduced cyst formation than controls. Fluorogold (FG) retrograde tracing revealed sparing/regeneration of supraspinal and local propriospinal axonal pathways, but no statistical differences were observed compared to controls. Immunohistochemical analysis revealed increased serotonergic (5-HT) and sensory (CGRP) axonal growth within and surrounding transplanted donor hMPCs 2 weeks posttransplantation, but no evidence of hMPC transdifferentiation was seen. Although hMPCs initially survive at 2 weeks posttransplantation, their numbers were dramatically reduced and no cells were detected at 8 weeks posttransplantation using retroviral/lentiviral GFP labeling and a human nuclear antigen (HNA) antibody. Additional immunosuppression with CsA did not improve hMPC survival or their ability to promote tissue sparing or functional recovery. We propose Stro-1 + -selected hMPCs provide (i) a reproducible source for stem cell transplantation for SC therapy and (ii) a positive host microenvironment resulting in the promotion of tissue sparing/repair that subsequently improves behavioral outcomes after SCI. Our results provide a new candidate for consideration as a stem cell therapy for the repair of traumatic CNS injury.
first_indexed 2024-12-19T05:54:20Z
format Article
id doaj.art-6f0817da116847d0afafc21f07d49014
institution Directory Open Access Journal
issn 0963-6897
1555-3892
language English
last_indexed 2024-12-19T05:54:20Z
publishDate 2013-03-01
publisher SAGE Publishing
record_format Article
series Cell Transplantation
spelling doaj.art-6f0817da116847d0afafc21f07d490142022-12-21T20:33:30ZengSAGE PublishingCell Transplantation0963-68971555-38922013-03-012210.3727/096368912X656081Human Mesenchymal Precursor Cells (Stro-1) from Spinal Cord Injury Patients Improve Functional Recovery and Tissue Sparing in an Acute Spinal Cord Injury Rat ModelStuart I. Hodgetts0Paul J. Simmons1Giles W. Plant2Eileen Bond Spinal Cord Research Laboratory, School of Anatomy and Human Biology, University of Western Australia, Perth, Western AustraliaBrown Foundation Institute of Molecular Medicine, University of Texas Health Science Center, Houston, TX, USAStanford Partnership for Spinal Cord Injury and Repair, Stanford Institute for Neuro-Innovation and Translational Neurosciences and Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA, USAThis study aimed to determine the potential of purified (Stro-1 + ) human mesenchymal precursor cells (hMPCs) to repair the injured spinal cord (SC) after transplantation into T-cell-deficient athymic RNU nude rats following acute moderate contusive spinal cord injury (SCI). hMPCs were isolated from the bone marrow (BM) stroma of SCI patients and transplanted as a suspension graft in medium [with or without immunosuppression using cyclosporin A (CsA)]. Extensive anatomical analysis shows statistically significant improvement in functional recovery, tissue sparing, and cyst reduction. We provide quantitative assessment of supraspinal projections in combination with functional outcomes. hMPC-transplanted animals consistently achieved mean BBB scores of 15 at 8 weeks postinjury. Quantitative histological staining revealed that graft-recipient animals possessed more intact spinal tissue and reduced cyst formation than controls. Fluorogold (FG) retrograde tracing revealed sparing/regeneration of supraspinal and local propriospinal axonal pathways, but no statistical differences were observed compared to controls. Immunohistochemical analysis revealed increased serotonergic (5-HT) and sensory (CGRP) axonal growth within and surrounding transplanted donor hMPCs 2 weeks posttransplantation, but no evidence of hMPC transdifferentiation was seen. Although hMPCs initially survive at 2 weeks posttransplantation, their numbers were dramatically reduced and no cells were detected at 8 weeks posttransplantation using retroviral/lentiviral GFP labeling and a human nuclear antigen (HNA) antibody. Additional immunosuppression with CsA did not improve hMPC survival or their ability to promote tissue sparing or functional recovery. We propose Stro-1 + -selected hMPCs provide (i) a reproducible source for stem cell transplantation for SC therapy and (ii) a positive host microenvironment resulting in the promotion of tissue sparing/repair that subsequently improves behavioral outcomes after SCI. Our results provide a new candidate for consideration as a stem cell therapy for the repair of traumatic CNS injury.https://doi.org/10.3727/096368912X656081
spellingShingle Stuart I. Hodgetts
Paul J. Simmons
Giles W. Plant
Human Mesenchymal Precursor Cells (Stro-1) from Spinal Cord Injury Patients Improve Functional Recovery and Tissue Sparing in an Acute Spinal Cord Injury Rat Model
Cell Transplantation
title Human Mesenchymal Precursor Cells (Stro-1) from Spinal Cord Injury Patients Improve Functional Recovery and Tissue Sparing in an Acute Spinal Cord Injury Rat Model
title_full Human Mesenchymal Precursor Cells (Stro-1) from Spinal Cord Injury Patients Improve Functional Recovery and Tissue Sparing in an Acute Spinal Cord Injury Rat Model
title_fullStr Human Mesenchymal Precursor Cells (Stro-1) from Spinal Cord Injury Patients Improve Functional Recovery and Tissue Sparing in an Acute Spinal Cord Injury Rat Model
title_full_unstemmed Human Mesenchymal Precursor Cells (Stro-1) from Spinal Cord Injury Patients Improve Functional Recovery and Tissue Sparing in an Acute Spinal Cord Injury Rat Model
title_short Human Mesenchymal Precursor Cells (Stro-1) from Spinal Cord Injury Patients Improve Functional Recovery and Tissue Sparing in an Acute Spinal Cord Injury Rat Model
title_sort human mesenchymal precursor cells stro 1 from spinal cord injury patients improve functional recovery and tissue sparing in an acute spinal cord injury rat model
url https://doi.org/10.3727/096368912X656081
work_keys_str_mv AT stuartihodgetts humanmesenchymalprecursorcellsstro1fromspinalcordinjurypatientsimprovefunctionalrecoveryandtissuesparinginanacutespinalcordinjuryratmodel
AT pauljsimmons humanmesenchymalprecursorcellsstro1fromspinalcordinjurypatientsimprovefunctionalrecoveryandtissuesparinginanacutespinalcordinjuryratmodel
AT gileswplant humanmesenchymalprecursorcellsstro1fromspinalcordinjurypatientsimprovefunctionalrecoveryandtissuesparinginanacutespinalcordinjuryratmodel